Signal transducer and activator of transcription 3 (STAT3) is highly expressed and overactivated in many tumors, including glioblastoma [44]; thus, targeting STAT3 could be a promising strategy for glioblastoma therapy [45]. This evidence concerns the gene STAT3 and glioblastoma.